Question: A 16-year-old patient has started on fluoxetine for moderate major depressive disorder during a follow-up visit two weeks later the patient reports feeling more anxious and having trouble sleeping the patient mother expressed is concerned about increased irritability mentions that the patient has been talking about feeling hopeless more frequently what should be the nurse practitioner most appropriate response regarding the FDA warning on SSRI suicide risk. Want Online Tutoring?